Wound healing: Part II. clinical applications

Plastic and Reconstructive Surgery

Volumn 133, Issue 3, 2014, Pages

  Janis, Jeffrey ^a   Harrison, Bridget ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOPICAL ANTIINFECTIVE AGENT;

ALGORITHM; ARTICLE; DEBRIDEMENT; HUMAN; INJURY; LAVAGE; PATHOPHYSIOLOGY; SCAR; VACUUM ASSISTED CLOSURE; WOUND HEALING;

ALGORITHMS; ANTI-INFECTIVE AGENTS, LOCAL; CICATRIX; DEBRIDEMENT; HUMANS; NEGATIVE-PRESSURE WOUND THERAPY; THERAPEUTIC IRRIGATION; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84897783858     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000077     Document Type: Article

References (92)

1. Petrisor B, Sun X, Bhandari M, et al. Fluid lavage of open wounds (FLOW): A multicenter, blinded, factorial pilot trial comparing alternative irrigating solutions and pressures in patients with open fractures. J Trauma 2011;71:596-606.
2. Moore Z, Cowman S. A systematic review of wound cleansing for pressure ulcers. J Clin Nurs. 2008;17:1963-1972.
3. Fernandez R, Griffths R. Water for wound cleansing. Cochrane Database Syst Rev. 2012;2:CD003861.
4. Brown LL, Shelton HT, Bornside GH, Cohn I Jr. Evaluation of wound irrigation by pulsatile jet and conventional methods. Ann Surg. 1978;187:170-173.
5. Stevenson TR, Thacker JG, Rodeheaver GT, Bacchetta C, Edgerton MT, Edlich RF. Cleansing the traumatic wound by high pressure syringe irrigation. JACEP 1976;5:17-21.
6. Tabor OB Jr, Bosse MJ, Hudson MC, et al. Does bacteremia occur during high pressure lavage of contaminated wounds? Clin Orthop Relat Res. 1998;347:117-121.
7. Boyd JI 3rd, Wongworawat MD. High-pressure pulsatile lavage causes soft tissue damage. Clin Orthop Relat Res. 2004;427:13-17.
8. Hassinger SM, Harding G, Wongworawat MD. High-pressure pulsatile lavage propagates bacteria into soft tissue. Clin Orthop Relat Res. 2005;439:27-31.
9. Kramer SA. Effect of povidone-iodine on wound healing: A review. J Vasc Nurs. 1999;17:17-23.
10. Gilmore OJ, Reid C, Strokon A. A study of the effect of povidone-iodine on wound healing. Postgrad Med J. 1977;53:122-125.
11. Vermeulen H, Westerbos SJ, Ubbink DT. Beneft and harm of iodine in wound care: A systematic review. J Hosp Infect. 2010;76:191-199.
12. Thorn RM, Austin AJ, Greenman J, Wilkins JP, Davis PJ. In vitro comparison of antimicrobial activity of iodine and silver dressings against bioflms. J Wound Care 2009;18: 343-346.
13. Atiyeh BS, Dibo SA, Hayek SN. Wound cleansing, topical antiseptics and wound healing. Int Wound J. 2009;6:420-430.
14. Thomas GW, Rael LT, Bar-Or R, et al. Mechanisms of delayed wound healing by commonly used antiseptics. J Trauma 2009;66:82-90; discussion 90.
15. Pan Q, Qiu WY, Huo YN, Yao YF, Lou MF. Low levels of hydrogen peroxide stimulate corneal epithelial cell adhesion, migration, and wound healing. Invest Ophthalmol Vis Sci.
16. Schreml S, Landthaler M, Schaferling M, et al. A new star on the H(2)O(2)rizon of wound healing? Exp Dermatol. 2011;20:229-231.
17. Noorani A, Rabey N, Walsh SR, Davies RJ. Systematic review and meta-analysis of preoperative antisepsis with chlorhexi-dine versus povidone-iodine in clean-contaminated surgery. Br J Surg. 2010;97:1614-1620.
18. Chlebicki MP, Safdar N, O'Horo JC, Maki DG. Preoperative chlorhexidine shower or bath for prevention of surgical site infection: A meta-analysis. Am J Infect Control. 2013;41:167-173.
19. Attinger CE, Janis JE, Steinberg J, et al. Clinical approach to wounds: Débridement and wound bed preparation including the use of dressings and wound-healing adjuvants. Plast Reconstr Surg. 2006;117:72S-109S.
20. Klein MB, Hunter S, Heimbach DM, et al. The Versajet water dissector: A new tool for tangential excision. J Burn Care Rehabil. 2005;26:483-487.
21. Allan N, Olson M, Nagel D, Martin R. The impact of VERSAJET hydrosurgical debridement on wounds containing bacterial bioflms. Wound Rep Regen. 2010;18:A88.
22. Granick MS, Posnett J, Jacoby M, Noruthun S, Ganchi PA, Datiashvili RO. Effcacy and cost-effectiveness of a high-powered parallel waterjet for wound debridement. Wound Repair Regen. 2006;14:394-397.
23. Sainsbury DC. Evaluation of the quality and cost-effectiveness of Versajet hydrosurgery. Int Wound J. 2009;6:24-29.
24. Boxer AM, Gottesman N, Bernstein H, Mandl I. Debridement of dermal ulcers and decubiti with collagenase. Geriatrics 1969;24:75-86.
25. Lee LK, Ambrus JL. Collagenase therapy for decubitus ulcers. Geriatrics 1975;30:91-93, 97.
26. Varma AO, Bugatch E, German FM. Debridement of dermal ulcers with collagenase. Surg Gynecol Obstet. 1973;136:281-282.
27. Soroff HS, Sasvary DH. Collagenase ointment and polymyxin B sulfate/bacitracin spray versus silver sulfadiazine cream in partial-thickness burns: A pilot study. J Burn Care Rehabil. 1994;15:13-17.
28. Miller JM. The interaction of papain, urea, and water-soluble chlorophyll in a proteolytic ointment for infected wounds. Surgery 1958;43:939-948.
29. Margolin L, Gialanella P. Assessment of the antimicrobial properties of maggots. Int Wound J. 2010;7:202-204.
30. Wollina U, Karte K, Herold C, Looks A. Biosurgery in wound healing: The renaissance of maggot therapy. J Eur Acad Dermatol Venereol. 2000;14:285-289.
31. Coldiron B. Closure of wounds under tension. Arch Dermatol. 1989;125:1189-1190.
32. Bucknall TE. Factors infuencing wound complications: A clinical and experimental study. Ann R Coll Surg Engl. 1983;65:71-77.
33. Osterberg B. Enclosure of bacteria within capillary multi-flament sutures as protection against leukocytes. Acta Chir Scand. 1983;149:663-668.
34. Stadler S, Fleck T. Triclosan-coated sutures for the reduction of sternal wound infections? A retrospective observational analysis. Interact Cardiovasc Thorac Surg. 2011;13:296-299.
35. Chang WK, Srinivasa S, Morton R, Hill AG. Triclosan-impregnated sutures to decrease surgical site infections: Systematic review and meta-analysis of randomized trials. Ann Surg. 2012;255:854-859.
36. Chantarasak ND, Milner RH. A comparison of scar quality in wounds closed under tension with PGA (Dexon) and Polydioxanone (PDS). Br J Plast Surg. 1989;42:687-691.
37. Singer AJ, Hollander JE, Valentine SM, Turque TW, McCuskey CF, Quinn JV. Prospective, randomized, controlled trial of tissue adhesive (2-octylcyanoacrylate) vs standard wound closure techniques for laceration repair. Stony Brook Octylcyanoacrylate Study Group. Acad Emerg Med. 1998;5:94-99.
38. Gennari R, Rotmensz N, Ballardini B, et al. A prospective, randomized, controlled clinical trial of tissue adhesive (2-octylcyanoacrylate) versus standard wound closure in breast surgery. Surgery 2004;136:593-599.
39. Quinn J, Wells G, Sutcliffe T, et al. Tissue adhesive versus suture wound repair at 1 year: Randomized clinical trial correlating early, 3-month, and 1-year cosmetic outcome. Ann Emerg Med. 1998;32:645-649.
40. Coulthard P, Esposito M, Worthington HV, et al. Tissue adhe-sives for closure of surgical incisions. Cochrane Database Syst Rev. 2010;5:CD004287.
41. Mustoe TA, Cooter RD, Gold MH, et al.; International Advisory Panel on Scar Management. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571.
42. Fulton JE Jr. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg. 1995;21:947-951.
43. Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical effcacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg. 2007;33:1291-1302; discussion 1302.
44. Hayashi T, Furukawa H, Oyama A, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38:893-897.
45. Sidle DM, Kim H. Keloids: Prevention and management. Facial Plast Surg Clin North Am. 2011;19:505-515.
46. Garcia-Velasco M, Ley R, Mutch D, Surkes N, Williams HB. Compression treatment of hypertrophic scars in burned children. Can J Surg. 1978;21:450-452.
47. Van den Kerckhove E, Stappaerts K, Fieuws S, et al. The assessment of erythema and thickness on burn related scars during pressure garment therapy as a preventive measure for hypertrophic scarring. Burns 2005;31:696-702.
48. Shin TM, Bordeaux JS. The role of massage in scar management: A literature review. Dermatol Surg. 2012;38: 414-423.
49. Khoo TL, Halim AS, Zakaria Z, Mat Saad AZ, Wu LY, Lau HY. A prospective, randomised, double-blinded trial to study the effcacy of topical tocotrienol in the prevention of hypertro-phic scars. J Plast Reconstr Aesthet Surg. 2011;64:e137-e145.
50. Baumann LS, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg. 1999;25:311-315.
51. Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg. 2002;110:177-183; discussion 184-186.
52. Chung VQ, Kelley L, Marra D, Jiang SB. Onion extract gel versus petrolatum emollient on new surgical scars: Prospective double-blinded study. Dermatol Surg. 2006;32:193-197.
53. Boykin JV. 5 questions-and answers-about hyperbaric oxygen therapy. Adv Skin Wound Care 2001;14:232, 234.
54. Kranke P, Morin AM, Roewer N, Eberhart LH. Patients' global evaluation of analgesia and safety of injected parecoxib for postoperative pain: A quantitative systematic review. Anesth Analg. 2004;99:797-806, table of contents.
55. Mounsey RA, Brown DH, O'Dwyer TP, Gullane PJ, Koch GH. Role of hyperbaric oxygen therapy in the management of mandibular osteoradionecrosis. Laryngoscope 1993;103:605-608.
56. Bennett MH, Feldmeier J, Hampson N, et al. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2012;5:CD005005.
57. Eguiluz-Ordoñez R, Sánchez CE, Venegas A, Figueroa-Granados V, Hernández-Pando R. Effects of hyperbaric oxygen on peripheral nerves. Plast Reconstr Surg. 2006;118:350-357; discussion 358.
58. Sanchez EC. Hyperbaric oxygenation in peripheral nerve repair and regeneration. Neurol Res. 2007;29:184-198.
59. Driver VR, Hanft J, Fylling CP, Beriou JM; Autologel Diabetic Foot Ulcer Study Group. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006;52:68-70, 72, 74 passim.
60. Alsousou J, Thompson M, Hulley P, Noble A, Willett K. The biology of platelet-rich plasma and its application in trauma and orthopaedic surgery: A review of the literature. J Bone Joint Surg Br. 2009;91:987-996.
61. Shake JG, Gruber PJ, Baumgartner WA, et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Annals Thorac Surg. 2002;73:1919-1925; discussion 1926.
62. Li Y, Chen J, Zhang CL, et al. Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 2005;49:407-417.
63. Kataoka K, Medina RJ, Kageyama T, et al. Participation of adult mouse bone marrow cells in reconstitution of skin. Am J Pathol. 2003;163:1227-1231.
64. Javazon EH, Keswani SG, Badillo AT, et al. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen. 2007;15:350-359.
65. Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res. 2009;12:359-366.
66. Jäger M, Jelinek EM, Wess KM, et al. Bone marrow concentrate: A novel strategy for bone defect treatment. Curr Stem Cell Res Ther. 2009;4:34-43.
67. Wongchuensoontorn C, Liebehenschel N, Schwarz U, et al. Application of a new chair-side method for the harvest of mes-enchymal stem cells in a patient with nonunion of a fracture of the atrophic mandible: A case report. J Craniomaxillofac Surg. 2009;37:155-161.
68. Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004;364:766-770.
69. Marcacci M, Kon E, Moukhachev V, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng. 2007;13:947-955.
70. Gir P, Oni G, Brown SA, Mojallal A, Rohrich RJ. Human adipose stem cells: Current clinical applications. Plast Reconstr Surg. 2012;129:1277-1290.
71. Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S. Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury. Stem Cells Int. 2010;2010:532704.
72. Lee DS, Sinno S, Khachemoune A. Honey and wound healing: an overview. Am J Clin Dermatol. 2011;12:181-190.
73. Al-Waili NS, Salom K, Butler G, Al Ghamdi AA. Honey and microbial infections: A review supporting the use of honey for microbial control. J Med Food 2011;14:1079-1096.
74. Wijesinghe M, Weatherall M, Perrin K, Beasley R. Honey in the treatment of burns: A systematic review and meta-analysis of its effcacy. N Z Med J. 2009;122:47-60.
75. Blaser G, Santos K, Bode U, Vetter H, Simon A. Effect of medical honey on wounds colonised or infected with MRSA. J Wound Care 2007;16:325-328.
76. Gethin G, Cowman S. Bacteriological changes in sloughy venous leg ulcers treated with manuka honey or hydrogel: An RCT. J Wound Care 2008;17:241-244, 246.
77. Hanazaki K, Maeda H, Okabayashi T. Relationship between perioperative glycemic control and postoperative infections. World J Gastroenterol. 2009;15:4122-4125.
78. Maeda Y, Loughrey A, Earle JA, et al. Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA). Complement Ther Clin Pract. 2008;14:77-82.
79. Argenta LC, Morykwas MJ. Vacuum-assisted closure: A new method for wound control and treatment: Clinical experience. Ann Plast Surg. 1997;38:563-576; discussion 577.
80. Glass GE, Nanchahal J. The methodology of negative pressure wound therapy: Separating fact from fction. J Plast Reconstr Aesthet Surg. 2012;65:989-1001.
81. Pietramaggiori G, Liu P, Scherer SS, et al. Tensile forces stimulate vascular remodeling and epidermal cell proliferation in living skin. Ann Surg. 2007;246:896-902.
82. Ingber DE, Folkman J. Mechanochemical switching between growth and differentiation during fbroblast growth factor-stimulated angiogenesis in vitro: Role of extracellular matrix. J Cell Biol. 1989;109:317-330.
83. Mouës CM, van Toorenenbergen AW, Heule F, Hop WC, Hovius SE. The role of topical negative pressure in wound repair: Expression of biochemical markers in wound fuid during wound healing. Wound Repair Regen. 2008;16:488-494.
84. Mendonca DA, Papini R, Price PE. Negative-pressure wound therapy: A snapshot of the evidence. Int Wound J. 2006;3:261-271.
85. Borgquist O, Anesäter E, Hedström E, Lee CK, Ingemansson R, Malmsjö M. Measurements of wound edge microvascular blood fow during negative pressure wound therapy using thermodiffusion and transcutaneous and invasive laser Doppler velocimetry. Wound Repair Regen. 2011;19:727-733.
86. Malmsjö M, Ingemansson R, Martin R, Huddleston E. Wound edge microvascular blood fow: Effects of negative pressure wound therapy using gauze or polyurethane foam. Ann Plast Surg. 2009;63:676-681.
87. Wackenfors A, Gustafsson R, Sjögren J, Algotsson L, Ingemansson R, Malmsjö M. Blood fow responses in the peristernal thoracic wall during vacuum-assisted closure therapy. Ann Thorac Surg. 2005;79:1724-1730; discussion 1730.
88. Weed T, Ratliff C, Drake DB. Quantifying bacterial biobur-den during negative pressure wound therapy: Does the wound VAC enhance bacterial clearance? Ann Plast Surg. 2004;52:276-279; discussion 279.
89. Khashram M, Huggan P, Ikram R, Chambers S, Roake JA, Lewis DR. Effect of TNP on the microbiology of venous leg ulcers: A pilot study. J Wound Care 2009;18:164-167.
90. Mouës CM, Vos MC, van den Bemd GJ, Stijnen T, Hovius SE. Bacterial load in relation to vacuum-assisted closure wound therapy: A prospective randomized trial. Wound Repair Regen. 2004;12:11-17.
91. Desai KK, Hahn E, Pulikkottil B, Pulikkotill B, Lee E. Negative pressure wound therapy: An algorithm. Clin Plast Surg. 2012;39:311-324.
92. Food and Drug Adminstration. FDA Safety Communication: Update on Serious Complications Associated with Negative Pressure Wound Therapy Systems. Vol. 2012. Washington, DC: Food and Drug Administration; 2011.